Determination of CCL2 / MCP-1 levels in the serum of children with melanocytic nevus in the postoperative period after using different methods of surgical treatment
Keywords:
children, pigmented nevi, CCL2 / MCP-1 level, operation.Abstract
To date, there are many methods and ways to remove pigmented skin tumors, which have their own indications and contraindications for use, early or late complications.The aim of the study was to determine the level of CCL2 / MCP-1 in the serum of patients with melanocyte skin nevi in the postoperative period with different methods of their removal.Materials and methods of research. The study involved 60 children with melanocyte skin nevi of different localization, who were hospitalized in the pediatric surgery clinic in the period from 2018 to 2020. All patients were divided into 3 groups : I group - the excision of the formation took place with a scalpel, group II - excision of the formation was performed using a high-intensity surgical laser, group III - excision of the formation using a high-frequency electrosurgical device "BOWA-ARC 350.Results and discussion. The results of studies showed an increase in the level of CCL2 / MCP-1 in the plasma of patients of group I in 2,6 times 12 hours after surgery and 3,15 times in 24 hours after surgery. A similar dynamics of increase in the level of CCL2 / MCP-1 in plasma was observed in patients of group II, but was more pronounced. The largest increase in CCL2 / MCP-1 levels was in comparison group III.Conclusions. High levels of CCL2 / MCP-1 in the plasma of patients of groups II and III 12 and 24 hours after surgery convincingly indicate the presence of a pronounced inflammatory reaction under the influence of thermal damaging factor on skin tissues.
References
Kolotov KA. Monotsitarnyy khemotaksicheskiy protein-1 v fiziologii i meditsine. Permskiy meditsinskiy zhurnal. 2018; T.35, №3: 99 – 105. [ in Russian ]
Takahashi M. Induction of monocyte chemoattractant protein-1 synthesis in human monocytes during transendothelial migration in vitro. Circulation Research. 1995; 76 (5): 750 – 57. doi: 10.116/01.RES.76.5.750
Liu S. Increased serum MCP-1 levels in systemic vasculitis patients with renal involvement. J. of Interferon & Cytokine Research. 2018; 38 (9): 406 – 12. doi.org/10.1089/jir.2017.0140
Traves SL. Increased levels of the chemokines GROα and MCP-1 in sputum samples from patients with COPD . Thorax. 2002; 57:590 – 95.
Matveyeva LV. Izmeneniya monotsitarnogo khemoattraktantnogo proteina-1 pri Helicobacter pylori-assotsiirovannykh gastroduodenal'nykh zabolevaniyakh. Infektsiya i immunitet. 2018; 8 (2): 150 – 56. [ in Russian ]
Jin HJ. Senescence associated MCP-1 secretion is dependent on a decline in BMI1 in human mesenchymal stromal cells. Antioxid. Redox. Signal. 2015; 17. doi: 10.1089/ars.2015.6359
Balatskaya NV., Kulikova IG., Kovaleva LA., Makarov PV. Proinflammatory chemokines in the development of systemic organ-specific sensitization in infectious corneal ulcers. Russian Ophthalmological Journal. 2020;13(2):65-70 https://doi.org/10.21516/2072-0076-2020-13-2-65-70
McNeill MS. Cell death of melanophores in zebrafishtrpm7 mutant embryos depends on melanin synthesis. J. of Investigative Dermatology. 2007; 127: 2020 – 30.
Ponomarev IV., Andrusenko YUN., Topchiy SB., Shakina LD. Udaleniye pal'pebral'nykh melanotsitarnykh nevusov dvukhvolnovym izlucheniyem lazera na parakh medi. Vestnik dermatologii i venerologii. 2020;96(5):47–52. doi: https://doi.org/10.25208/vdv1138-2020-96-5-47-52 [ in Russian ]
Ikonnikova EV., Stenko AG., Korchazkina NB. The modern methods for the correction of non-neoplastic melanin hyperpigmentation of the skin and the integrated approach to their treatment. Fizioterapiya, Bal’nеologiya i Reabilitatsiya (Russian Journal of the Physical Therapy, Balneotherapy and Rehabilitation). 2017; 16 (2): 84-88. (In Russ.). DOI: http://dx.doi.org/10.18821/1681-3456-2017-16-2-84-88
Helsinki Declaration of the World Medical Association "Ethical principles of medical research with human participation as an object of study": adopted by the 18th General Assembly of the Military Medical Academy, Helsinki, Finland, June 1964; edition from 01.10.2008 [Electronic resource] // Legislation of Ukraine. - Available: http://zakon5.rada.gov.ua/laws/show/990_005
Lee WJ. The effect of MCP-1/CCR2 on the proliferation and senescence of epidermal constituent cells in solar lentigo. Int. J. Mol. Sci. 2016; 17: 948; doi:10.3390/ijms17060948
Damsky WE. Melanocytic nevi and melanoma: unraveling a complex relationship. Oncogene. 2017; 36(42): 5771 – 92/ doi:10.1038/onc.2017.189
Noemi GS. Targeting tumor-associated macrophages and inhibition of MCP-1 reduce angiogenesis and tumor growth in a human melanoma xenograft. J. of investigative Dermatology. 2007; 127(8) : 2031 – 41.
Wang X. Serum cytokine profiles of melanoma patients and their association with tumor progression and metastasis. Hindawi J. of Oncology. 2021; 1: 9. doi: org.10.1155/2021/6610769
Tang M. Endogenous PGE2 induces MCP-1 expression via EP4/p38 MAPK signaling in melanoma. Oncology letters. 2013; 5: 645 – 50. doi: 10.3892/ol.2012.1047
Was H. Effect of heme oxygenase-1 on melanoma development in mice – role of tumor-infiltrating immune cells. Antioxidants. 2020; 9: 1 – 21. doi: 10.3390/antiox9121223
McNeill M.S. Cell death of melanophores in zebrafishtrpm7 mutant embryos depends on melanin synthesis. J. of Investigative Dermatology. 2007; 127: 2020 – 30.
Behfara S. A brief look at the role of monocyte chemoattractant protein-1 (CCL2) in the pathophysiology of psoriasis. Cytokine. 2018;110:226-31. doi.org/10.1016/j.cyto.2017.12.010
Nesbit M. Low-level monocyte chemoattractant protein-1 stimulation of monocytes leads to tumor formation in nontumorigenic melanoma cells. The Journal of Immunology. 2001; 166: 6483 – 6490.
Behfara S. A brief look at the role of monocyte chemoattractant protein-1 (CCL2) in the pathophysiology of psoriasis. Cytokine. 2018; 110: 226-31. doi.org/10.1016/j.cyto.2017.12.010
Yoshimura T. Non-myeloid cells are major contributors to innate immune responses via production of monocyte chemoattractant protein-1/CCL2. Frontiers in immunology. – 2014; 4 (482): 1 – 6.
Dmytriiev D., Dmytriiev K., Stoliarchuk O., & Semenenko, A. (2019). Multiple organ dysfunction syndrome: what do we know about pain management? A narrative review. Anaesthesia, Pain & Intensive Care. 2019; 23(1): 84-91
Kruglov SS., Gelfond ML., Tyndyk ML., Maydin MA., Grishacheva TG., Basina RM., Gubareva EA., Plakhov EA., Kireeva GS., Panchenko A.V. Methodological aspects of photodynamic therapy of ehrlich solid carcinoma in BALB/C mouse strain with various tumor localization. Siberian Journal of Oncology. 2020; 19(6): 82–92. – doi: 10.21294/1814- 4861-2020-19-6-82-92.
Downloads
Published
Issue
Section
License
Copyright (c) 2021 Publisher
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Transfer of Copyright and Permission to Reproduce Parts of Published Papers.
Authors retain the copyright for their published work. No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.
How to Cite
